Skip to content

Meta-analysis finds high but variable STI rates in PrEP studies – is PrEP the cause or a potential solution?

Removable PrEP implant produces high drug levels in rabbits; further studies planned

PROUD qualitative findings: PrEP’s impact on sexual behaviour

Transgender women taking PrEP have lower levels of PrEP drugs, especially in rectal tissues, than cisgender men

Transgender women taking PrEP have lower levels of PrEP drugs, especially in rectal tissues, than cisgender men

How safe is PrEP? Meta-analysis finds no increased risk of serious side-effects

How safe is PrEP? Meta-analysis finds no increased risk of serious side-effects

Going local – prevention conference hears about rings, douches, and soluble suppositories

Image from Karl Malcolm's slides at HIVR4P 2018.

Beyond Truvada – what is the future of PrEP?

Raphael Landovitz at HIVR4P 2018. Photo by Roger Pebody.

Boston HIV clinic sees 90% reduction in infections in people being prescribed PrEP

Raphael Landovitz, Jared Baeten and Ken Mayer at HIVR4P 2018. © HIVR4P/ Leon Gutierrez

First large HIV prevention trial using antibodies will probably not be the last

Lynn Morris at HIVR4P 2018. Photo by Gus Cairns.